Next Article in Journal
Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer
Next Article in Special Issue
Clinical Significance of Glycolytic Metabolic Activity in Hepatocellular Carcinoma
Previous Article in Journal
Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG)
Previous Article in Special Issue
Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know
 
 
Article

Article Versions Notes

Cancers 2022, 14(17), 4207; https://doi.org/10.3390/cancers14174207
Action Date Notes Link
article xml file uploaded 30 August 2022 13:05 CEST Original file -
article xml uploaded. 30 August 2022 13:05 CEST Update https://www.mdpi.com/2072-6694/14/17/4207/xml
article pdf uploaded. 30 August 2022 13:05 CEST Version of Record https://www.mdpi.com/2072-6694/14/17/4207/pdf
article html file updated 30 August 2022 13:07 CEST Original file -
article html file updated 28 February 2023 11:28 CET Update https://www.mdpi.com/2072-6694/14/17/4207/html
Back to TopTop